

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.44148224 |
| 2 | proteasome assembly (GO:0043248) | 5.23616321 |
| 3 | DNA deamination (GO:0045006) | 4.99672904 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.86148718 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.67009060 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 4.67009060 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 4.64560416 |
| 8 | proline biosynthetic process (GO:0006561) | 4.25154097 |
| 9 | ribosomal small subunit biogenesis (GO:0042274) | 4.22743841 |
| 10 | protein maturation by protein folding (GO:0022417) | 4.21016559 |
| 11 | respiratory chain complex IV assembly (GO:0008535) | 4.17743086 |
| 12 | protein complex biogenesis (GO:0070271) | 4.17402540 |
| 13 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.11984174 |
| 14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.08769852 |
| 15 | cotranslational protein targeting to membrane (GO:0006613) | 4.07055411 |
| 16 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.02100140 |
| 17 | heme biosynthetic process (GO:0006783) | 4.01333648 |
| 18 | termination of RNA polymerase III transcription (GO:0006386) | 4.00998866 |
| 19 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.00998866 |
| 20 | protein targeting to ER (GO:0045047) | 4.00466355 |
| 21 | cytochrome complex assembly (GO:0017004) | 3.96204010 |
| 22 | viral transcription (GO:0019083) | 3.94939752 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.93162282 |
| 24 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.88719074 |
| 25 | protein localization to endoplasmic reticulum (GO:0070972) | 3.86801788 |
| 26 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.81642285 |
| 27 | maturation of SSU-rRNA (GO:0030490) | 3.79561611 |
| 28 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.78829105 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.78750304 |
| 30 | translational termination (GO:0006415) | 3.78273975 |
| 31 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.74712856 |
| 32 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.74712856 |
| 33 | NADH dehydrogenase complex assembly (GO:0010257) | 3.74712856 |
| 34 | GDP-mannose metabolic process (GO:0019673) | 3.72807105 |
| 35 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.70944270 |
| 36 | peptidyl-histidine modification (GO:0018202) | 3.70637592 |
| 37 | respiratory electron transport chain (GO:0022904) | 3.69433523 |
| 38 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.69081478 |
| 39 | regulation of mitochondrial translation (GO:0070129) | 3.68296448 |
| 40 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.67498056 |
| 41 | negative regulation of ligase activity (GO:0051352) | 3.66764795 |
| 42 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.66764795 |
| 43 | rRNA modification (GO:0000154) | 3.66724932 |
| 44 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.65472172 |
| 45 | protein localization to mitochondrion (GO:0070585) | 3.65197539 |
| 46 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.64596913 |
| 47 | viral protein processing (GO:0019082) | 3.62437214 |
| 48 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.62006213 |
| 49 | heme metabolic process (GO:0042168) | 3.60630132 |
| 50 | electron transport chain (GO:0022900) | 3.60542010 |
| 51 | signal peptide processing (GO:0006465) | 3.59693336 |
| 52 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.55192507 |
| 53 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.55192507 |
| 54 | pseudouridine synthesis (GO:0001522) | 3.53724631 |
| 55 | protein neddylation (GO:0045116) | 3.53250672 |
| 56 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.53097843 |
| 57 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.53097843 |
| 58 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.53097843 |
| 59 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.52854643 |
| 60 | GTP biosynthetic process (GO:0006183) | 3.52790903 |
| 61 | 7-methylguanosine mRNA capping (GO:0006370) | 3.47949361 |
| 62 | 7-methylguanosine RNA capping (GO:0009452) | 3.45648350 |
| 63 | RNA capping (GO:0036260) | 3.45648350 |
| 64 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.42600425 |
| 65 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.38970205 |
| 66 | translation (GO:0006412) | 3.37827827 |
| 67 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.37657478 |
| 68 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.36613540 |
| 69 | translational elongation (GO:0006414) | 3.34714221 |
| 70 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.33587318 |
| 71 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.33587318 |
| 72 | cullin deneddylation (GO:0010388) | 3.32610120 |
| 73 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.31891683 |
| 74 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.31271811 |
| 75 | rRNA methylation (GO:0031167) | 3.27618940 |
| 76 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.25767581 |
| 77 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.25767581 |
| 78 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.25367460 |
| 79 | oxidative phosphorylation (GO:0006119) | 3.24774910 |
| 80 | regulation of ligase activity (GO:0051340) | 3.24555503 |
| 81 | tetrapyrrole biosynthetic process (GO:0033014) | 3.23955263 |
| 82 | protein deneddylation (GO:0000338) | 3.20635280 |
| 83 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.20194762 |
| 84 | viral life cycle (GO:0019058) | 3.19479473 |
| 85 | protein-cofactor linkage (GO:0018065) | 3.17816825 |
| 86 | GMP metabolic process (GO:0046037) | 3.16514908 |
| 87 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.16153760 |
| 88 | protein targeting to mitochondrion (GO:0006626) | 3.15483911 |
| 89 | cellular response to oxygen radical (GO:0071450) | 3.12932258 |
| 90 | removal of superoxide radicals (GO:0019430) | 3.12932258 |
| 91 | cellular response to superoxide (GO:0071451) | 3.12932258 |
| 92 | porphyrin-containing compound metabolic process (GO:0006778) | 3.07368409 |
| 93 | establishment of integrated proviral latency (GO:0075713) | 3.06472139 |
| 94 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.05816363 |
| 95 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.04739527 |
| 96 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.03317753 |
| 97 | cellular protein complex disassembly (GO:0043624) | 3.03233635 |
| 98 | UTP biosynthetic process (GO:0006228) | 3.01450609 |
| 99 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.00422285 |
| 100 | establishment of protein localization to mitochondrion (GO:0072655) | 2.99370238 |
| 101 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.98120974 |
| 102 | oxygen transport (GO:0015671) | 2.96516799 |
| 103 | iron-sulfur cluster assembly (GO:0016226) | 2.95415950 |
| 104 | metallo-sulfur cluster assembly (GO:0031163) | 2.95415950 |
| 105 | negative regulation of protein ubiquitination (GO:0031397) | 2.95025131 |
| 106 | spliceosomal snRNP assembly (GO:0000387) | 2.94859499 |
| 107 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.93726756 |
| 108 | translational initiation (GO:0006413) | 2.92108082 |
| 109 | maturation of 5.8S rRNA (GO:0000460) | 2.91582023 |
| 110 | DNA strand elongation (GO:0022616) | 2.91561412 |
| 111 | pentose metabolic process (GO:0019321) | 2.90991963 |
| 112 | nucleoside salvage (GO:0043174) | 2.90543791 |
| 113 | establishment of viral latency (GO:0019043) | 2.89600439 |
| 114 | positive regulation of ligase activity (GO:0051351) | 2.88836399 |
| 115 | cellular component biogenesis (GO:0044085) | 2.88142335 |
| 116 | COPI coating of Golgi vesicle (GO:0048205) | 2.87497890 |
| 117 | Golgi transport vesicle coating (GO:0048200) | 2.87497890 |
| 118 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.87354197 |
| 119 | ribosomal large subunit biogenesis (GO:0042273) | 2.87065639 |
| 120 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.86071194 |
| 121 | regulation of cellular amine metabolic process (GO:0033238) | 2.84302290 |
| 122 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.84017892 |
| 123 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.83786972 |
| 124 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.78133968 |
| 125 | positive regulation of cell cycle arrest (GO:0071158) | 2.76984919 |
| 126 | CTP biosynthetic process (GO:0006241) | 2.74437008 |
| 127 | CTP metabolic process (GO:0046036) | 2.74437008 |
| 128 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.71240768 |
| 129 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.71214305 |
| 130 | sequestering of actin monomers (GO:0042989) | 2.69414858 |
| 131 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.69213545 |
| 132 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.68534780 |
| 133 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.68534780 |
| 134 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.67824848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.04381730 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.72248783 |
| 3 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.60155897 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.14737765 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.11569400 |
| 6 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.05303251 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.69028603 |
| 8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.40889760 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.37533540 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.30823975 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.17172205 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.11556041 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.09871098 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.06759220 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.84683793 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.70609389 |
| 17 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.68326782 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.65630874 |
| 19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.62668686 |
| 20 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.51669121 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.40449772 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34035568 |
| 23 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30870104 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.23578700 |
| 25 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.12342284 |
| 26 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.11143659 |
| 27 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.08916113 |
| 28 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.06723169 |
| 29 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.06464006 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.06442699 |
| 31 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06134273 |
| 32 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.05113433 |
| 33 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.03606811 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.01508880 |
| 35 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.96951067 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.95137962 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.91970348 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87948720 |
| 39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.79654584 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76647184 |
| 41 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.75418971 |
| 42 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.72132252 |
| 43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.70588802 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.67631500 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60548982 |
| 46 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.57318731 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57207523 |
| 48 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.56674696 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53320947 |
| 50 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.52730729 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50000341 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48231035 |
| 53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.48173682 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38105175 |
| 55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.37282117 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37085124 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36025620 |
| 58 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.33805563 |
| 59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29668558 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28701527 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28430322 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25375066 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.25012030 |
| 64 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.22122141 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21425602 |
| 66 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21136956 |
| 67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20651983 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16091585 |
| 69 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.15662681 |
| 70 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15646894 |
| 71 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.15219785 |
| 72 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.14718020 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14374045 |
| 74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14020738 |
| 75 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13150090 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.11581358 |
| 77 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.10274892 |
| 78 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.09590796 |
| 79 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.09070967 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 1.07095298 |
| 81 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05645597 |
| 82 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.04909172 |
| 83 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04244955 |
| 84 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03979332 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03833337 |
| 86 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03643614 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.03296096 |
| 88 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03266899 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03217057 |
| 90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03034917 |
| 91 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.02011314 |
| 92 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01870172 |
| 93 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.01479257 |
| 94 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98140022 |
| 95 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.98080941 |
| 96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98033281 |
| 97 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97595461 |
| 98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96714470 |
| 99 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.96105809 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95351497 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95122351 |
| 102 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.93700069 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92334020 |
| 104 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.92305288 |
| 105 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.92146490 |
| 106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92124391 |
| 107 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.91960970 |
| 108 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91800512 |
| 109 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.91211113 |
| 110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.90851560 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90775463 |
| 112 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.90677371 |
| 113 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.90495577 |
| 114 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90031292 |
| 115 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.86802046 |
| 116 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.85931735 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85677759 |
| 118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84937159 |
| 119 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.84383891 |
| 120 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.83016127 |
| 121 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.81947761 |
| 122 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81908973 |
| 123 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.81779224 |
| 124 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.81196636 |
| 125 | VDR_22108803_ChIP-Seq_LS180_Human | 0.80239085 |
| 126 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.78431281 |
| 127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77756840 |
| 128 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.74902573 |
| 129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74329927 |
| 130 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.73656073 |
| 131 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.73161512 |
| 132 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.72578780 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71145169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.63784056 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.35526626 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.30794701 |
| 4 | MP0005083_abnormal_biliary_tract | 2.97039749 |
| 5 | MP0001986_abnormal_taste_sensitivity | 2.95724806 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.88044721 |
| 7 | MP0009785_altered_susceptibility_to | 2.74523912 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 2.52724348 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.48604640 |
| 10 | MP0001529_abnormal_vocalization | 2.45042898 |
| 11 | MP0005671_abnormal_response_to | 2.32232408 |
| 12 | MP0003880_abnormal_central_pattern | 2.31135084 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.28563830 |
| 14 | MP0002638_abnormal_pupillary_reflex | 2.11351953 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.09948930 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.08648128 |
| 17 | MP0003724_increased_susceptibility_to | 2.06734844 |
| 18 | MP0003693_abnormal_embryo_hatching | 1.99044002 |
| 19 | MP0001905_abnormal_dopamine_level | 1.98459422 |
| 20 | MP0001188_hyperpigmentation | 1.94782179 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.93754774 |
| 22 | MP0003186_abnormal_redox_activity | 1.91480542 |
| 23 | MP0000015_abnormal_ear_pigmentation | 1.83981780 |
| 24 | MP0000358_abnormal_cell_content/ | 1.82688936 |
| 25 | MP0005025_abnormal_response_to | 1.82266249 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.81990156 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.80178187 |
| 28 | MP0000685_abnormal_immune_system | 1.77908984 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.73152265 |
| 30 | MP0008058_abnormal_DNA_repair | 1.72262474 |
| 31 | MP0002132_abnormal_respiratory_system | 1.68141843 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.66626619 |
| 33 | MP0002163_abnormal_gland_morphology | 1.65016794 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.64124172 |
| 35 | MP0001819_abnormal_immune_cell | 1.63887693 |
| 36 | MP0002723_abnormal_immune_serum | 1.63221489 |
| 37 | MP0002419_abnormal_innate_immunity | 1.60950194 |
| 38 | MP0005451_abnormal_body_composition | 1.59964639 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.59256084 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.57065264 |
| 41 | MP0006082_CNS_inflammation | 1.55258480 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.54149067 |
| 43 | MP0001542_abnormal_bone_strength | 1.53753842 |
| 44 | MP0009840_abnormal_foam_cell | 1.51352705 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.46552229 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.46552229 |
| 47 | MP0004957_abnormal_blastocyst_morpholog | 1.45485284 |
| 48 | MP0000681_abnormal_thyroid_gland | 1.45152328 |
| 49 | MP0000313_abnormal_cell_death | 1.43651931 |
| 50 | MP0008995_early_reproductive_senescence | 1.42411692 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.40495552 |
| 52 | MP0004142_abnormal_muscle_tone | 1.39013703 |
| 53 | MP0005379_endocrine/exocrine_gland_phen | 1.37182064 |
| 54 | MP0001800_abnormal_humoral_immune | 1.35316924 |
| 55 | MP0005387_immune_system_phenotype | 1.34899538 |
| 56 | MP0001790_abnormal_immune_system | 1.34899538 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.34559311 |
| 58 | MP0001853_heart_inflammation | 1.31118592 |
| 59 | MP0002095_abnormal_skin_pigmentation | 1.28522521 |
| 60 | MP0002933_joint_inflammation | 1.25517277 |
| 61 | MP0003436_decreased_susceptibility_to | 1.25373116 |
| 62 | MP0002398_abnormal_bone_marrow | 1.25077815 |
| 63 | MP0002736_abnormal_nociception_after | 1.24837500 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 1.23924644 |
| 65 | MP0000678_abnormal_parathyroid_gland | 1.23447272 |
| 66 | MP0005501_abnormal_skin_physiology | 1.22432945 |
| 67 | MP0003136_yellow_coat_color | 1.21131316 |
| 68 | MP0004147_increased_porphyrin_level | 1.21102295 |
| 69 | MP0009278_abnormal_bone_marrow | 1.20748149 |
| 70 | MP0005171_absent_coat_pigmentation | 1.20041766 |
| 71 | MP0000716_abnormal_immune_system | 1.18201263 |
| 72 | MP0008875_abnormal_xenobiotic_pharmacok | 1.17468641 |
| 73 | MP0001730_embryonic_growth_arrest | 1.17171475 |
| 74 | MP0008932_abnormal_embryonic_tissue | 1.16158264 |
| 75 | MP0010386_abnormal_urinary_bladder | 1.15631908 |
| 76 | MP0002405_respiratory_system_inflammati | 1.11770808 |
| 77 | MP0003786_premature_aging | 1.09276638 |
| 78 | MP0001873_stomach_inflammation | 1.09188098 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 1.09066887 |
| 80 | MP0005408_hypopigmentation | 1.08871009 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 1.08600153 |
| 82 | MP0005646_abnormal_pituitary_gland | 1.08130077 |
| 83 | MP0000350_abnormal_cell_proliferation | 1.06622274 |
| 84 | MP0002429_abnormal_blood_cell | 1.05507520 |
| 85 | MP0001727_abnormal_embryo_implantation | 1.04040790 |
| 86 | MP0008260_abnormal_autophagy | 1.03163425 |
| 87 | MP0005332_abnormal_amino_acid | 1.02728698 |
| 88 | MP0005410_abnormal_fertilization | 1.02306018 |
| 89 | MP0002938_white_spotting | 1.01827080 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 1.01226839 |
| 91 | MP0000689_abnormal_spleen_morphology | 1.00741121 |
| 92 | MP0001764_abnormal_homeostasis | 1.00525518 |
| 93 | MP0002751_abnormal_autonomic_nervous | 1.00367758 |
| 94 | MP0002080_prenatal_lethality | 0.99831200 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.99676077 |
| 96 | MP0003866_abnormal_defecation | 0.99517924 |
| 97 | MP0005409_darkened_coat_color | 0.98671420 |
| 98 | MP0008007_abnormal_cellular_replicative | 0.98144741 |
| 99 | MP0005330_cardiomyopathy | 0.98075888 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 0.97073493 |
| 101 | MP0003718_maternal_effect | 0.96834759 |
| 102 | MP0001845_abnormal_inflammatory_respons | 0.94217102 |
| 103 | MP0002722_abnormal_immune_system | 0.94210871 |
| 104 | MP0003123_paternal_imprinting | 0.94102888 |
| 105 | MP0001881_abnormal_mammary_gland | 0.94058876 |
| 106 | MP0000343_altered_response_to | 0.94012559 |
| 107 | MP0002653_abnormal_ependyma_morphology | 0.93821752 |
| 108 | MP0004381_abnormal_hair_follicle | 0.93613850 |
| 109 | MP0001984_abnormal_olfaction | 0.93564872 |
| 110 | MP0003077_abnormal_cell_cycle | 0.93024616 |
| 111 | MP0002272_abnormal_nervous_system | 0.92195241 |
| 112 | MP0005310_abnormal_salivary_gland | 0.88594583 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88299200 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.87818032 |
| 115 | MP0000490_abnormal_crypts_of | 0.86765437 |
| 116 | MP0008873_increased_physiological_sensi | 0.86331642 |
| 117 | MP0003879_abnormal_hair_cell | 0.85818563 |
| 118 | MP0001661_extended_life_span | 0.85218983 |
| 119 | MP0006276_abnormal_autonomic_nervous | 0.84415836 |
| 120 | MP0000858_altered_metastatic_potential | 0.83269329 |
| 121 | MP0008872_abnormal_physiological_respon | 0.83200072 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.83081126 |
| 123 | MP0000750_abnormal_muscle_regeneration | 0.82766828 |
| 124 | MP0000920_abnormal_myelination | 0.81917550 |
| 125 | MP0002693_abnormal_pancreas_physiology | 0.81849625 |
| 126 | MP0004233_abnormal_muscle_weight | 0.81543474 |
| 127 | MP0008789_abnormal_olfactory_epithelium | 0.81463765 |
| 128 | MP0001968_abnormal_touch/_nociception | 0.80202512 |
| 129 | MP0008469_abnormal_protein_level | 0.79995203 |
| 130 | MP0010094_abnormal_chromosome_stability | 0.79144525 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.78721584 |
| 132 | MP0002396_abnormal_hematopoietic_system | 0.78639380 |
| 133 | MP0009765_abnormal_xenobiotic_induced | 0.78347187 |
| 134 | MP0003950_abnormal_plasma_membrane | 0.78228830 |
| 135 | MP0005464_abnormal_platelet_physiology | 0.75846412 |
| 136 | MP0002210_abnormal_sex_determination | 0.74744056 |
| 137 | MP0001533_abnormal_skeleton_physiology | 0.74456793 |
| 138 | MP0001929_abnormal_gametogenesis | 0.72607495 |
| 139 | MP0001697_abnormal_embryo_size | 0.72076770 |
| 140 | MP0009763_increased_sensitivity_to | 0.71053002 |
| 141 | MP0001851_eye_inflammation | 0.71051961 |
| 142 | MP0005384_cellular_phenotype | 0.70680380 |
| 143 | MP0009697_abnormal_copulation | 0.70047378 |
| 144 | MP0006035_abnormal_mitochondrial_morpho | 0.69754784 |
| 145 | MP0004510_myositis | 0.69469319 |
| 146 | MP0001970_abnormal_pain_threshold | 0.69172772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.94564551 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.83895553 |
| 3 | Increased hepatocellular lipid droplets (HP:0006565) | 4.61120892 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.57742879 |
| 5 | Hepatocellular necrosis (HP:0001404) | 4.19196291 |
| 6 | Renal Fanconi syndrome (HP:0001994) | 4.12552737 |
| 7 | Increased CSF lactate (HP:0002490) | 4.08239212 |
| 8 | Acute encephalopathy (HP:0006846) | 4.06660692 |
| 9 | Testicular atrophy (HP:0000029) | 4.01690261 |
| 10 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.94808024 |
| 11 | Lipid accumulation in hepatocytes (HP:0006561) | 3.93801192 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.89917911 |
| 13 | Exertional dyspnea (HP:0002875) | 3.81250464 |
| 14 | 3-Methylglutaconic aciduria (HP:0003535) | 3.77720520 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.68541780 |
| 16 | Hepatic necrosis (HP:0002605) | 3.63620781 |
| 17 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.55336485 |
| 18 | Abnormal number of erythroid precursors (HP:0012131) | 3.54330709 |
| 19 | Cholecystitis (HP:0001082) | 3.52272205 |
| 20 | Abnormal gallbladder physiology (HP:0012438) | 3.52272205 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.49445162 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.49445162 |
| 23 | Type I transferrin isoform profile (HP:0003642) | 3.41619917 |
| 24 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.18196999 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 3.17964135 |
| 26 | Poor head control (HP:0002421) | 3.15108458 |
| 27 | Reticulocytopenia (HP:0001896) | 3.07908417 |
| 28 | Increased serum lactate (HP:0002151) | 3.04046053 |
| 29 | Abnormal hemoglobin (HP:0011902) | 3.01439655 |
| 30 | Cholelithiasis (HP:0001081) | 3.00707795 |
| 31 | Aplastic anemia (HP:0001915) | 3.00700820 |
| 32 | Abnormal gallbladder morphology (HP:0012437) | 2.78197156 |
| 33 | Exercise intolerance (HP:0003546) | 2.76578638 |
| 34 | Abnormality of renal resorption (HP:0011038) | 2.69753730 |
| 35 | Respiratory difficulties (HP:0002880) | 2.67820372 |
| 36 | Lactic acidosis (HP:0003128) | 2.61822290 |
| 37 | Respiratory failure (HP:0002878) | 2.60341447 |
| 38 | Optic disc pallor (HP:0000543) | 2.56206690 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56167176 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.53565304 |
| 41 | Petechiae (HP:0000967) | 2.52643426 |
| 42 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.52192318 |
| 43 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.52192318 |
| 44 | Abnormal protein glycosylation (HP:0012346) | 2.52192318 |
| 45 | Abnormal glycosylation (HP:0012345) | 2.52192318 |
| 46 | Hypothermia (HP:0002045) | 2.50192694 |
| 47 | Abnormal hair whorl (HP:0010721) | 2.49201886 |
| 48 | Increased serum pyruvate (HP:0003542) | 2.48311930 |
| 49 | Abnormality of glycolysis (HP:0004366) | 2.48311930 |
| 50 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.48022973 |
| 51 | Leukodystrophy (HP:0002415) | 2.46481964 |
| 52 | Recurrent abscess formation (HP:0002722) | 2.45480838 |
| 53 | Microretrognathia (HP:0000308) | 2.41965211 |
| 54 | Ragged-red muscle fibers (HP:0003200) | 2.39996463 |
| 55 | Degeneration of anterior horn cells (HP:0002398) | 2.36686901 |
| 56 | Abnormality of the anterior horn cell (HP:0006802) | 2.36686901 |
| 57 | Pallor (HP:0000980) | 2.35494878 |
| 58 | Increased IgM level (HP:0003496) | 2.34708923 |
| 59 | Macrocytic anemia (HP:0001972) | 2.31371370 |
| 60 | Birth length less than 3rd percentile (HP:0003561) | 2.30888995 |
| 61 | Progressive microcephaly (HP:0000253) | 2.29992718 |
| 62 | Reticulocytosis (HP:0001923) | 2.29688697 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.26956044 |
| 64 | Severe visual impairment (HP:0001141) | 2.23913134 |
| 65 | Abnormality of the gallbladder (HP:0005264) | 2.23795585 |
| 66 | Spastic paraparesis (HP:0002313) | 2.20856155 |
| 67 | Lethargy (HP:0001254) | 2.18227890 |
| 68 | Ileus (HP:0002595) | 2.17781152 |
| 69 | True hermaphroditism (HP:0010459) | 2.17776474 |
| 70 | Medial flaring of the eyebrow (HP:0010747) | 2.17598097 |
| 71 | Reduced antithrombin III activity (HP:0001976) | 2.17228828 |
| 72 | Opisthotonus (HP:0002179) | 2.15097202 |
| 73 | Stomatitis (HP:0010280) | 2.12416169 |
| 74 | Upper limb muscle weakness (HP:0003484) | 2.11524149 |
| 75 | Abnormality of reticulocytes (HP:0004312) | 2.11419746 |
| 76 | Delusions (HP:0000746) | 2.11241652 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08819297 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.08819297 |
| 79 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.08183133 |
| 80 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.08155175 |
| 81 | Recurrent bacterial skin infections (HP:0005406) | 2.07303407 |
| 82 | Oral leukoplakia (HP:0002745) | 2.02860337 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.02673835 |
| 84 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99589420 |
| 85 | Irregular epiphyses (HP:0010582) | 1.98143853 |
| 86 | Hyperphosphaturia (HP:0003109) | 1.97008621 |
| 87 | Progressive muscle weakness (HP:0003323) | 1.96328285 |
| 88 | Cerebral palsy (HP:0100021) | 1.94635530 |
| 89 | Hypertensive crisis (HP:0100735) | 1.94391773 |
| 90 | Hypokinesia (HP:0002375) | 1.94246272 |
| 91 | Parakeratosis (HP:0001036) | 1.94153893 |
| 92 | Secondary amenorrhea (HP:0000869) | 1.91944396 |
| 93 | Pancytopenia (HP:0001876) | 1.90161345 |
| 94 | IgG deficiency (HP:0004315) | 1.89983956 |
| 95 | Squamous cell carcinoma (HP:0002860) | 1.89033397 |
| 96 | Cerebral edema (HP:0002181) | 1.87503201 |
| 97 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87490072 |
| 98 | Increased serum ferritin (HP:0003281) | 1.87403662 |
| 99 | Methylmalonic acidemia (HP:0002912) | 1.86482097 |
| 100 | Paralysis (HP:0003470) | 1.86480941 |
| 101 | Rough bone trabeculation (HP:0100670) | 1.86265196 |
| 102 | 11 pairs of ribs (HP:0000878) | 1.85881446 |
| 103 | Vacuolated lymphocytes (HP:0001922) | 1.85522714 |
| 104 | Myositis (HP:0100614) | 1.85204381 |
| 105 | Microvesicular hepatic steatosis (HP:0001414) | 1.84858909 |
| 106 | Acute hepatic failure (HP:0006554) | 1.83618089 |
| 107 | IgM deficiency (HP:0002850) | 1.83080439 |
| 108 | Renal tubular dysfunction (HP:0000124) | 1.83054282 |
| 109 | Dysautonomia (HP:0002459) | 1.82914894 |
| 110 | Prolonged neonatal jaundice (HP:0006579) | 1.82505852 |
| 111 | Nausea (HP:0002018) | 1.82274557 |
| 112 | Abnormality of urine glucose concentration (HP:0011016) | 1.81243863 |
| 113 | Glycosuria (HP:0003076) | 1.81243863 |
| 114 | Abnormality of dental color (HP:0011073) | 1.80964346 |
| 115 | Cerebral hypomyelination (HP:0006808) | 1.80820149 |
| 116 | Hepatosplenomegaly (HP:0001433) | 1.80645011 |
| 117 | Hyperbilirubinemia (HP:0002904) | 1.80029967 |
| 118 | Cleft eyelid (HP:0000625) | 1.78789655 |
| 119 | Neuroendocrine neoplasm (HP:0100634) | 1.78696380 |
| 120 | Premature graying of hair (HP:0002216) | 1.78613866 |
| 121 | Type 2 muscle fiber atrophy (HP:0003554) | 1.78158087 |
| 122 | Abnormality of macrophages (HP:0004311) | 1.77531981 |
| 123 | Neutropenia (HP:0001875) | 1.74848113 |
| 124 | Progressive neurologic deterioration (HP:0002344) | 1.73345700 |
| 125 | Poor suck (HP:0002033) | 1.73229336 |
| 126 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.71236328 |
| 127 | Sparse eyelashes (HP:0000653) | 1.71184848 |
| 128 | Pancreatic cysts (HP:0001737) | 1.70137981 |
| 129 | Microcytic anemia (HP:0001935) | 1.69809643 |
| 130 | Nephrogenic diabetes insipidus (HP:0009806) | 1.69094213 |
| 131 | Premature ovarian failure (HP:0008209) | 1.68990591 |
| 132 | Muscle fiber atrophy (HP:0100295) | 1.63519704 |
| 133 | CNS demyelination (HP:0007305) | 1.61905249 |
| 134 | Mediastinal lymphadenopathy (HP:0100721) | 1.59481139 |
| 135 | Eczematoid dermatitis (HP:0000976) | 1.58655008 |
| 136 | Stenosis of the external auditory canal (HP:0000402) | 1.58478764 |
| 137 | Pancreatic fibrosis (HP:0100732) | 1.57908203 |
| 138 | Methylmalonic aciduria (HP:0012120) | 1.57678688 |
| 139 | Abnormality of magnesium homeostasis (HP:0004921) | 1.56995607 |
| 140 | Congenital primary aphakia (HP:0007707) | 1.56305663 |
| 141 | Emotional lability (HP:0000712) | 1.55810719 |
| 142 | Purpura (HP:0000979) | 1.55596080 |
| 143 | Abnormal trabecular bone morphology (HP:0100671) | 1.55577635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.46296796 |
| 2 | STK16 | 4.00827970 |
| 3 | MAP3K12 | 3.42311819 |
| 4 | NME2 | 3.40546197 |
| 5 | BUB1 | 3.21797807 |
| 6 | PIM2 | 2.52434352 |
| 7 | SRPK1 | 2.50887199 |
| 8 | VRK1 | 2.41455291 |
| 9 | ARAF | 2.28049476 |
| 10 | IRAK4 | 2.18808284 |
| 11 | TESK2 | 2.12803783 |
| 12 | NME1 | 2.11412326 |
| 13 | CDK19 | 2.08918118 |
| 14 | EIF2AK1 | 2.04972658 |
| 15 | PBK | 2.04089670 |
| 16 | EIF2AK3 | 1.96270885 |
| 17 | TXK | 1.78581810 |
| 18 | BMPR2 | 1.76660558 |
| 19 | BRAF | 1.60662184 |
| 20 | TNIK | 1.59769492 |
| 21 | IRAK3 | 1.57654138 |
| 22 | TAOK2 | 1.55097791 |
| 23 | KIT | 1.51549270 |
| 24 | MYLK | 1.51331729 |
| 25 | SCYL2 | 1.50504612 |
| 26 | CASK | 1.49223263 |
| 27 | PDK2 | 1.43189623 |
| 28 | TRIM28 | 1.39496858 |
| 29 | MAP2K7 | 1.36912399 |
| 30 | DYRK2 | 1.36614484 |
| 31 | NEK1 | 1.35469057 |
| 32 | PAK4 | 1.33140519 |
| 33 | EPHA2 | 1.26758650 |
| 34 | BMPR1B | 1.26636138 |
| 35 | TSSK6 | 1.22072278 |
| 36 | SMG1 | 1.19723725 |
| 37 | SIK3 | 1.18394608 |
| 38 | MST4 | 1.18045079 |
| 39 | MUSK | 1.15695124 |
| 40 | TEC | 1.15611352 |
| 41 | ADRBK2 | 1.14757003 |
| 42 | LIMK1 | 1.14455123 |
| 43 | ZAP70 | 1.13264254 |
| 44 | CDC7 | 1.11592300 |
| 45 | WEE1 | 1.11165278 |
| 46 | SYK | 1.10003612 |
| 47 | MKNK1 | 1.08954703 |
| 48 | TESK1 | 1.08446110 |
| 49 | MAPKAPK3 | 1.08371580 |
| 50 | TAOK1 | 1.07838939 |
| 51 | BLK | 1.06342745 |
| 52 | MAP4K2 | 1.04149818 |
| 53 | GRK6 | 1.03115345 |
| 54 | CLK1 | 1.02624609 |
| 55 | PRPF4B | 1.02247478 |
| 56 | ERN1 | 0.98825332 |
| 57 | CCNB1 | 0.96854127 |
| 58 | MAP4K1 | 0.95698745 |
| 59 | PLK1 | 0.91251574 |
| 60 | MAP3K14 | 0.90992800 |
| 61 | RIPK4 | 0.90344993 |
| 62 | MAP2K3 | 0.89807930 |
| 63 | TTK | 0.87879476 |
| 64 | CSNK1A1L | 0.86514335 |
| 65 | TBK1 | 0.86349758 |
| 66 | ERBB3 | 0.83335769 |
| 67 | IRAK2 | 0.82875191 |
| 68 | BRSK2 | 0.82496861 |
| 69 | EIF2AK2 | 0.81430485 |
| 70 | BMX | 0.80627649 |
| 71 | LMTK2 | 0.80205633 |
| 72 | LRRK2 | 0.79981095 |
| 73 | TLK1 | 0.79976722 |
| 74 | ILK | 0.77999187 |
| 75 | ACVR1B | 0.76680909 |
| 76 | MAPKAPK5 | 0.75942024 |
| 77 | CDK7 | 0.74710687 |
| 78 | BCR | 0.74604005 |
| 79 | MAP3K3 | 0.74369200 |
| 80 | NLK | 0.74257910 |
| 81 | OXSR1 | 0.73679662 |
| 82 | ATR | 0.72842941 |
| 83 | DAPK1 | 0.71997243 |
| 84 | CDK8 | 0.70765135 |
| 85 | BTK | 0.70745787 |
| 86 | CSNK1G1 | 0.70112179 |
| 87 | MAP3K8 | 0.69932670 |
| 88 | YES1 | 0.69891513 |
| 89 | TNK2 | 0.69682988 |
| 90 | STK4 | 0.69434717 |
| 91 | IKBKB | 0.68230838 |
| 92 | IKBKE | 0.68212303 |
| 93 | NUAK1 | 0.67805267 |
| 94 | AURKB | 0.66822682 |
| 95 | LYN | 0.66056387 |
| 96 | MAP3K11 | 0.63933592 |
| 97 | PLK4 | 0.63637802 |
| 98 | GRK7 | 0.63554200 |
| 99 | KDR | 0.61529511 |
| 100 | IRAK1 | 0.61355527 |
| 101 | AURKA | 0.61194943 |
| 102 | MKNK2 | 0.60258439 |
| 103 | CHEK2 | 0.59897930 |
| 104 | MAPK13 | 0.59893835 |
| 105 | PLK2 | 0.55773317 |
| 106 | CSNK1G2 | 0.55692415 |
| 107 | CSNK2A1 | 0.55186541 |
| 108 | BCKDK | 0.53697360 |
| 109 | BRSK1 | 0.52057892 |
| 110 | STK10 | 0.51581787 |
| 111 | PLK3 | 0.51234083 |
| 112 | DYRK3 | 0.51072843 |
| 113 | WNK4 | 0.51015522 |
| 114 | PRKCI | 0.49152965 |
| 115 | ABL2 | 0.49041077 |
| 116 | ZAK | 0.48979161 |
| 117 | PASK | 0.47691090 |
| 118 | GRK5 | 0.46371082 |
| 119 | RPS6KA5 | 0.45776171 |
| 120 | MST1R | 0.44086003 |
| 121 | UHMK1 | 0.42359692 |
| 122 | DAPK3 | 0.42213253 |
| 123 | MAP2K2 | 0.40974850 |
| 124 | PRKCD | 0.40969658 |
| 125 | RPS6KB2 | 0.40875502 |
| 126 | CSNK1G3 | 0.40119957 |
| 127 | PRKD3 | 0.39365548 |
| 128 | MAP2K6 | 0.38604024 |
| 129 | CDK14 | 0.38283342 |
| 130 | LCK | 0.38075875 |
| 131 | CAMK2B | 0.37992807 |
| 132 | PAK1 | 0.37377200 |
| 133 | TIE1 | 0.37024310 |
| 134 | CSNK2A2 | 0.36378523 |
| 135 | PRKD2 | 0.36254522 |
| 136 | RPS6KA4 | 0.34191656 |
| 137 | CHEK1 | 0.33473003 |
| 138 | NEK6 | 0.33125885 |
| 139 | RAF1 | 0.32912348 |
| 140 | CDK18 | 0.32284924 |
| 141 | PRKCE | 0.31660424 |
| 142 | CDK11A | 0.31624663 |
| 143 | MOS | 0.29530367 |
| 144 | MATK | 0.28166686 |
| 145 | TAF1 | 0.28127986 |
| 146 | MAP3K5 | 0.27518586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.45280060 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.25504118 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.93797967 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.75389460 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.36640874 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.29982566 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.81664392 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.46748706 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.34942365 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.31269219 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.24569776 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.23090693 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.02872692 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.92132936 |
| 15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.86445596 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.81559380 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.80281702 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.67526394 |
| 19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.63143003 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.62307929 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.57720333 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.56054484 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.54795541 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.50440712 |
| 25 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.50071598 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.48173747 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.45066755 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42407113 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38713467 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.33869007 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31596513 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.24730617 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.23952733 |
| 34 | * Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.19909692 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.17448810 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15473446 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06779440 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.06558712 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05922145 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03860822 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03655199 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01327419 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99836741 |
| 44 | RNA degradation_Homo sapiens_hsa03018 | 0.99681627 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99173447 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94750461 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90101791 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89170171 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89050946 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 0.88653174 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88217300 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82822101 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82528259 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.79430015 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78292841 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.78238389 |
| 57 | RNA transport_Homo sapiens_hsa03013 | 0.76905806 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75635237 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74771915 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74385832 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74164623 |
| 62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73392159 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71694601 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.71382512 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70422378 |
| 66 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69268462 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68246292 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64324811 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63982894 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.63348911 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62900403 |
| 72 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62646078 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61709377 |
| 74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61564587 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60716629 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58911262 |
| 77 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57717919 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.57110704 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.56283147 |
| 80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.56157598 |
| 81 | Cell cycle_Homo sapiens_hsa04110 | 0.55917782 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.54717859 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54564895 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54088628 |
| 85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53181558 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.52597458 |
| 87 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.52574962 |
| 88 | Leishmaniasis_Homo sapiens_hsa05140 | 0.50829884 |
| 89 | Malaria_Homo sapiens_hsa05144 | 0.50352199 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47870973 |
| 91 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47808886 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47609550 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.46726504 |
| 94 | Measles_Homo sapiens_hsa05162 | 0.46523297 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45766089 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44148028 |
| 97 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43438595 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42504224 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42032824 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40872012 |
| 101 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40847363 |
| 102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40495117 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38801883 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38507593 |
| 105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37730176 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37236498 |
| 107 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35381131 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35276588 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34498015 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.33187602 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32046835 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31619497 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.31450835 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31189456 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29894314 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29859274 |
| 117 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.29766041 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.29357302 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26386728 |
| 120 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26148154 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25823675 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24245126 |
| 123 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.20743516 |
| 124 | Nicotine addiction_Homo sapiens_hsa05033 | 0.19977051 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.18947270 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.18838324 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18504471 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.18429715 |
| 129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.15875488 |
| 130 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.12689349 |
| 131 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.12536638 |
| 132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.12438887 |
| 133 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.08710585 |

